Drugmaker Novartis to close 450-employee Sandoz plant in Broomfield
Swiss drugmaker Novartis AG plans to reduce or drop production of some generic drugs and will close its 450-employee Sandoz plant in Broomfield over the next two years as a result.
The Sandoz facility has been in Broomfield for 42 years.
Novartis (NYSE: NVS) plans to consolidate production of drug ingredients at a sister plant in Wilson, North Carolina, and shut down the Broomfield manufacturing plant by the end of 2019, the company said.
“With several products no longe r competitive in saturated…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Greg Avery Source Type: news
More News: Health Management | Switzerland Health